Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFM.L Regulatory News (AFM)

  • There is currently no data for AFM

Form 8.3 - AFM LN

12 Jul 2024 15:30

RNS Number : 2538W
Syquant Capital
12 July 2024
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Alpha Financial

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

July 11, 2024

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

0.075p ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,813,237

1.48%

Β 

Β 

(2) Derivatives (other than options):

674,463

0.55%

Β 

(3) Options and agreements to purchase/sell:

Β 

Β 

Β 

Β 

TOTAL:

2,487,700

2.03%

Β 

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

0.075 ordinary

Purchase

Β 

344,470

494 GBp

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.075p ordinary

Β 

CFD

Β 

increasing a long position

Β 

5,530

Β 

494 GBp

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

July 12, 2024

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETQKBBBKBKDCOD
Date   Source Headline
8th Jan 20247:01 amRNSTR-1: Notification of major holdings
8th Jan 20247:00 amRNSTR-1: Notification of major holdings
24th Nov 202311:32 amRNSInvestor Presentation via Investor Meet Company
23rd Nov 20237:00 amRNSInterim Results
19th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSPre-close trading update
26th Sep 202312:33 pmRNSTR-1: Notification of major holdings
31st Aug 20233:33 pmRNSHolding(s) in Company
17th Aug 202312:00 pmRNSExercise of share awards and total voting rights
4th Aug 20237:00 amRNSPublication of ARA and Notice of AGM
1st Aug 20237:00 amRNSTotal Voting Rights
5th Jul 20237:00 amRNSGrant of incentive awards, new shares and TVR
23rd Jun 20237:00 amRNSRSU vesting, PDMR dealing and total voting rights
22nd Jun 20237:00 amRNSFull Year Audited Results
2nd May 20237:00 amRNSAcquisition of Shoreline
11th Apr 20237:00 amRNSHolding(s) in Company
3rd Apr 20237:01 amRNSConfirmation of Chief Executive Officer Start Date
3rd Apr 20237:00 amRNSTotal Voting Rights
9th Mar 20237:00 amRNSTrading update and Capital Markets presentation
1st Mar 20237:00 amRNSTotal Voting Rights
23rd Feb 20239:00 amRNSExercise of share awards and total voting rights
3rd Jan 20237:00 amRNSTotal Voting Rights
2nd Dec 202212:17 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSExercise of options and issue of equity
23rd Nov 202212:01 pmEQSAlpha FMC growing quickly five years on from AIM listing
23rd Nov 20227:01 amRNSChief Executive Officer Succession
23rd Nov 20227:00 amRNSInterim Results
11th Nov 20224:41 pmRNSSecond Price Monitoring Extn
11th Nov 20224:36 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSVesting of options and total voting rights
11th Oct 20227:00 amRNSPre-close trading update
13th Sep 202212:56 pmRNSResult of AGM
5th Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSExercise of share awards and total voting rights
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20225:00 pmRNSPublication of Annual Report and Notice of AGM
15th Jul 20227:00 amRNSHolding(s) in Company
11th Jul 202212:00 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSPDMR dealing
4th Jul 20227:00 amRNSIssue of new shares, grant of incentive awards
1st Jul 20227:00 amRNSTotal Voting Rights
28th Jun 20227:00 amRNSExercise of options and total voting rights
23rd Jun 20227:00 amRNSFull Year Audited Results
19th Apr 202212:00 pmRNSHolding(s) in Company
7th Apr 20227:01 amRNSNon-Executive Director Appointment
7th Apr 20227:00 amRNSTrading Update
4th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSTotal Voting Rights
23rd Mar 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.